Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Atherosclerosis IV: Nursing Management

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...

Lipid Absorption

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Global atmospheric state analysis using objective Gaussian probability density functions.

Scientific reports·2024

Same author

D-Dimer Is a Predictive Factor of Cancer Therapeutics-Related Cardiac Dysfunction in Patients Treated With Cardiotoxic Chemotherapy.

Frontiers in cardiovascular medicine·2022

Same author

Prognostic Value of the Pattern of Non-Adherence to Anti-Platelet Regimen in Stented Patients (PARIS) Bleeding Risk Score for Long-Term Mortality After Percutaneous Coronary Intervention.

International heart journal·2022

Same author

Left ventricular mass index-to-QRS-voltage ratio predicts outcomes in heart failure with preserved ejection fraction.

ESC heart failure·2022

Same author

Procedural characteristics of pulmonary vein isolation with high-power short-duration setting compared to conventional setting.

BMC cardiovascular disorders·2022

Same author

Perforation of the membranous atrioventricular septum caused by infective endocarditis in a patient with a unicuspid aortic valve.

Journal of medical ultrasonics (2001)·2022

Search research articles

Related Experiment Video

Updated: Jun 7, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Ezetimibe and vascular inflammation.

Toshiyuki Ishibashi¹, Yasuchika Takeishi

¹Department of Cardiology and Hematology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.

Current Vascular Pharmacology

|November 4, 2010

Summary

This summary is machine-generated.

Ezetimibe monotherapy

Related Experiment Videos

Last Updated: Jun 7, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Area of Science:

Cardiovascular Medicine
Vascular Biology
Pharmacology

Background:

Atherosclerosis is an inflammatory vascular disease linked to hyperlipidemia.
Statins lower cholesterol and C-reactive protein (CRP), a marker of inflammation.
Ezetimibe, an intestinal cholesterol absorption inhibitor, is used for hypercholesterolemia.

Purpose of the Study:

To review clinical trials on ezetimibe monotherapy, statin monotherapy, and combination therapy.
To assess the impact of these therapies on low-density lipoprotein cholesterol (LDL-C) and vascular inflammation.
To define the effect of ezetimibe monotherapy on CRP reduction.

Main Methods:

Review of recently described clinical trials.
Analysis of studies involving ezetimibe monotherapy.
Analysis of studies involving statin monotherapy.
Analysis of studies involving combined ezetimibe and statin therapy.

Main Results:

Combined ezetimibe and statin therapy shows greater reductions in LDL-C and CRP compared to monotherapy.
The effect of ezetimibe monotherapy on CRP reduction requires further definition.
Long-term statin use may increase intestinal cholesterol absorption.

Conclusions:

Ezetimibe combined with statins offers potent LDL-C and CRP reduction.
Further research is needed to fully understand ezetimibe monotherapy's impact on vascular inflammation.
Targeting intestinal cholesterol absorption is a viable strategy in managing hypercholesterolemia and atherosclerosis.